Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With no annotations, the description carries the full disclosure burden and does real work: it enumerates the payload (list version, last check, last change dates), names the source jurisdictions (MFDS, CosIng, FDA, plus 7 more markets), and explicitly bounds the tool ('not a safety rating, a lab test or medical advice'). It stops short of describing the response envelope beyond the url/cite fields.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The core purpose leads the sentence, followed by the attribution requirement and the scope disclaimer. It is dense but every element does work, though the licensing/disclaimer clauses run long relative to the operational content.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a zero-param, no-output-schema tool, the description covers what comes back (per-market source type, version, check/change dates) and the citation fields (url/cite), which is most of what an agent needs. Minor gaps remain on the overall result shape, but nothing essential for correct invocation is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The tool takes zero parameters and the schema is empty, so the baseline of 4 applies. The description correctly implies a no-argument call that returns all markets at once.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description states concretely what the tool returns: the official regulatory lists behind the data, per market, including whether rules come from the authority's own list or a secondary compilation, plus list version and last check/change dates. It implicitly separates itself from the retrieval siblings (get_product, lookup_ingredient, search_*) by being a provenance/metadata endpoint, though it never names an alternative outright.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

Usage guidance is present but aimed at citation behavior ('name KBeauty Verified™ and link the exact page URL'), not at when to call this tool versus about or recent_updates. The condition for selecting this endpoint must be inferred from the content it describes rather than stated.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.